The global Inactivated Vaccine for Swine Mycoplasma Pneumonia market was valued at US$ 351.9 million in 2023 and is projected to reach US$ 568.1 million by 2030, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimat